| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
24,631,000 | 22,971,000 | 22,419,000 | 21,601,000 | 19,705,000 |
| Cost of Revenue
|
-5,849,000 | -5,600,000 | -5,329,000 | -5,281,000 | -5,036,000 |
|
Gross Profit
|
18,782,000 | 17,371,000 | 17,090,000 | 16,320,000 | 14,669,000 |
| Selling, General and Administrative Expenses
|
-13,155,000 | -12,046,000 | -11,391,000 | -10,656,000 | -10,270,000 |
|
Research and Development Expenses
|
-1,414,000 | -1,401,000 | -1,394,000 | -1,226,000 | -1,314,000 |
| Other Income/Expense, Operating
|
-- | -- | -- | -- | 0 |
|
Operating Income/Expenses
|
-14,569,000 | -13,447,000 | -12,785,000 | -11,882,000 | -11,584,000 |
|
Total Operating Profit/Loss
|
4,213,000 | 3,924,000 | 4,305,000 | 4,438,000 | 3,085,000 |
| Total Net Finance Income/Expense
|
-676,000 | -683,000 | -767,000 | -612,000 | -267,000 |
| Net Investment Income
|
-16,000 | -12,000 | 54,000 | -81,000 | 109,000 |
| Irregular Income/Expenses
|
-344,000 | -128,000 | 124,000 | 0 | -- |
|
Non-Operating Income/Expenses, Total
|
-1,036,000 | -823,000 | -589,000 | -693,000 | -158,000 |
|
Pretax Income
|
3,177,000 | 3,101,000 | 3,716,000 | 3,745,000 | 2,927,000 |
|
Provision for Income Tax
|
-755,000 | -734,000 | -824,000 | -922,000 | -651,000 |
|
Net Income from Continuing Operations
|
2,422,000 | 2,367,000 | 2,892,000 | 2,823,000 | 2,276,000 |
|
Discontinued Operations
|
-810,000 | -823,000 | -504,000 | -1,025,000 | -192,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,612,000 | 1,544,000 | 2,388,000 | 1,798,000 | 2,084,000 |
|
Non-Controlling/Minority Interests
|
2,000 | 1,000 | -1,000 | -3,000 | -2,000 |
|
Net Income after Non-Controlling/Minority Interests
|
1,614,000 | 1,545,000 | 2,387,000 | 1,795,000 | 2,082,000 |
|
Net Income Available to Common Stockholders
|
1,614,000 | 1,545,000 | 2,387,000 | 1,795,000 | 2,082,000 |
|
Diluted Net Income Available to Common Stockholders
|
1,614,000 | 1,545,000 | 2,387,000 | 1,795,000 | 2,082,000 |
| Basic EPS
|
7.65 | 7.31 | 10.99 | 8.04 | 9.21 |
| Diluted EPS
|
7.65 | 7.31 | 10.99 | 8.04 | 9.21 |
|
Basic Weighted Average Shares Outstanding
|
211,049.50 | 211,310 | 217,220 | 223,130 | 226,010 |
|
Diluted Weighted Average Shares Outstanding
|
211,049.50 | 211,310 | 217,220 | 223,130 | 226,010 |
|
Reported Normalized Basic EPS
|
11.74 | 11.74 | 12.74 | -- | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
3,629,000 | 3,560,000 | 4,267,000 | 4,192,000 | 3,062,000 |
|
EBITDA
|
3,629,000 | 5,079,000 | 5,702,000 | 5,526,000 | 4,248,000 |
|
Normalized EBITDA
|
3,757,000 | 5,301,000 | 5,544,000 | 5,486,000 | 4,196,000 |
12/31/2022 - 5/8/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade